Home > Income Statement > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Revenue

    Back to Income Statement
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2013Mar2012
Net Sales ₹301 Cr₹278 Cr₹13,770,298 Cr₹124 Cr₹124 Cr

What is the latest Revenue of NATH BIOGENES (INDIA) ?

The latest Revenue ratio of NATH BIOGENES (INDIA) is ₹301 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹301 Cr
Mar2023₹278 Cr
Mar2022₹13,770,298 Cr
Mar2013₹124 Cr
Mar2012₹124 Cr

How is Revenue of NATH BIOGENES (INDIA) Trending?

Years Revenue % Change
Mar2024 ₹301 Cr
8.26
Mar2023 ₹278 Cr
-100.00
Mar2022 ₹13,770,298 Cr
11,112,596.80
Mar2013 ₹124 Cr
0.00
Mar2012 ₹124 Cr -

Compare Revenue of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹377.2 Cr -2.4% 5.6% -1% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,934.7 Cr -5.8% -6.3% 14.7% Stock Analytics
KAVERI SEED COMPANY ₹6,436.8 Cr -5.7% -15.3% 32.9% Stock Analytics
VENKYS (INDIA) ₹2,264.3 Cr -1.5% 0.4% -16.7% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,435.5 Cr -2% -1.8% -33.7% Stock Analytics
INDO US BIOTECH ₹307.9 Cr 1.5% 1.6% -27% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-2.4%

5.6%

-1%

SENSEX

1.6%

1%

7%


You may also like the below Video Courses